Company · CIK 0001731831
Eidos Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/AEidos Therapeutics, Inc.0001193125-21-017128 · 33.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-017109 · 381.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-012447 · 208.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-006784 · 529.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001564590-20-048909 · 9.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-048894 · 594.2 KBSEC(opens sec.gov)
- SC 13D/AEidos Therapeutics, Inc.0001104659-20-113116 · 67.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-264980 · 976.7 KBSEC(opens sec.gov)
- SC 13D/AEidos Therapeutics, Inc.0001193125-20-264026 · 557.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-263868 · 212.6 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO, CA, 94104
mailing
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO, CA, 94104
Same industry